These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22252998)

  • 21. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis.
    Giordana MT; Piccinini M; Grifoni S; De Marco G; Vercellino M; Magistrello M; Pellerino A; Buccinnà B; Lupino E; Rinaudo MT
    Brain Pathol; 2010 Mar; 20(2):351-60. PubMed ID: 19338576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
    Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
    Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.
    Liu YJ; Kuo HC; Chern Y
    Neurobiol Dis; 2021 Dec; 160():105531. PubMed ID: 34634461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo.
    Xue YC; Ruller CM; Fung G; Mohamud Y; Deng H; Liu H; Zhang J; Feuer R; Luo H
    Am J Pathol; 2018 Dec; 188(12):2853-2862. PubMed ID: 30273599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optineurin defects cause TDP43-pathology with autophagic vacuolar formation.
    Kurashige T; Kuramochi M; Ohsawa R; Yamashita Y; Shioi G; Morino H; Kamada M; Ayaki T; Ito H; Sotomaru Y; Maruyama H; Kawakami H
    Neurobiol Dis; 2021 Jan; 148():105215. PubMed ID: 33296728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology.
    Tudor EL; Galtrey CM; Perkinton MS; Lau KF; De Vos KJ; Mitchell JC; Ackerley S; Hortobágyi T; Vámos E; Leigh PN; Klasen C; McLoughlin DM; Shaw CE; Miller CC
    Neuroscience; 2010 May; 167(3):774-85. PubMed ID: 20188146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
    Smethurst P; Sidle KC; Hardy J
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis.
    Tibshirani M; Zhao B; Gentil BJ; Minotti S; Marques C; Keith J; Rogaeva E; Zinman L; Rouaux C; Robertson J; Durham HD
    Hum Mol Genet; 2017 Nov; 26(21):4142-4152. PubMed ID: 28973294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
    Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
    J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis.
    Yabata H; Riku Y; Miyahara H; Akagi A; Sone J; Urushitani M; Yoshida M; Iwasaki Y
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.
    Mori F; Tanji K; Miki Y; Wakabayashi K
    J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal Expression of Mutant TDP-43 Correlates with Early Amyotrophic Lateral Sclerosis Phenotype and Motor Weakness.
    Chen Q; Zhou J; Huang C; Huang B; Bi F; Zhou H; Xiao B
    Curr Neurovasc Res; 2018; 15(1):3-9. PubMed ID: 29313467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
    Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
    Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
    Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
    Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.